Form 4: Onconetix Interim CEO Ralph Schiess Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Ralph Schiess, Interim CEO and CSO of Onconetix, Inc., reports acquiring and disposing of common stock on December 20, 2024.
Summary
- On December 20, 2024, Ralph Schiess, the Interim CEO and CSO of Onconetix, Inc., engaged in transactions involving the company's common stock.
- Schiess acquired 177,462 shares of common stock at a price of $0.
- Schiess disposed of an unspecified amount of shares.
- Following these transactions, Schiess beneficially owns 673,365 shares of Onconetix common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- Shareholders are informed about the trading activities of a key executive.
Key Dates
| Date | Description |
|---|---|
| 12/20/2024 | Date of transaction involving acquisition and disposal of common stock. |
| 01/22/2025 | Date of signature for the report. |
Keywords
Form 4, Onconetix, Schiess, Common Stock, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.